ATE414540T1 - Impfstoffe gegen allergien - Google Patents
Impfstoffe gegen allergienInfo
- Publication number
- ATE414540T1 ATE414540T1 AT03740967T AT03740967T ATE414540T1 AT E414540 T1 ATE414540 T1 AT E414540T1 AT 03740967 T AT03740967 T AT 03740967T AT 03740967 T AT03740967 T AT 03740967T AT E414540 T1 ATE414540 T1 AT E414540T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccines against
- against allergies
- polypeptides
- allergies
- adjuvants
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000007815 allergy Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40864802P | 2002-09-05 | 2002-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE414540T1 true ATE414540T1 (de) | 2008-12-15 |
Family
ID=31978650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03740967T ATE414540T1 (de) | 2002-09-05 | 2003-06-02 | Impfstoffe gegen allergien |
Country Status (9)
Country | Link |
---|---|
US (2) | US20040054146A1 (de) |
EP (1) | EP1545607B1 (de) |
JP (1) | JP2006510588A (de) |
AT (1) | ATE414540T1 (de) |
AU (1) | AU2003297953B2 (de) |
CA (1) | CA2497660A1 (de) |
DE (1) | DE60324816D1 (de) |
ES (1) | ES2316780T3 (de) |
WO (1) | WO2004022094A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080118524A1 (en) * | 2006-10-20 | 2008-05-22 | Stefan Persson | Anti-IgE Vaccines |
JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | eMIPを有効成分とする水溶性製剤 |
GB2500204A (en) * | 2012-03-13 | 2013-09-18 | Intercell Ag | Vaccine comprising aluminium adjuvant having low levels of contaminating heavy metal ions |
US9895437B2 (en) | 2012-04-18 | 2018-02-20 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3876763A (en) * | 1970-12-29 | 1975-04-08 | Shionogi & Co | Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof |
US4873191A (en) * | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
JPH03503403A (ja) * | 1987-07-06 | 1991-08-01 | ペプチド テクノロジー リミテッド | 生物学的に活性な分子 |
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
SE9102808L (sv) * | 1991-09-26 | 1993-03-27 | Lars T Hellman Inst F Immunolo | Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner |
US6913749B2 (en) * | 1998-11-02 | 2005-07-05 | Resistentia Pharmaceuticals Ab | Immunogenic polypeptides for inducing anti-self IgE responses |
EP1967205B1 (de) * | 2000-08-30 | 2012-10-10 | Pfizer Products Inc. | Anti-IgE Vakzine |
WO2003096966A2 (en) * | 2002-05-21 | 2003-11-27 | Resistentia Pharmaceuticals Ab | Chimeric ige polypeptides and host cells |
-
2003
- 2003-06-02 AU AU2003297953A patent/AU2003297953B2/en not_active Ceased
- 2003-06-02 DE DE60324816T patent/DE60324816D1/de not_active Expired - Fee Related
- 2003-06-02 JP JP2004533694A patent/JP2006510588A/ja active Pending
- 2003-06-02 EP EP03740967A patent/EP1545607B1/de not_active Expired - Lifetime
- 2003-06-02 WO PCT/IB2003/003075 patent/WO2004022094A1/en active Application Filing
- 2003-06-02 CA CA002497660A patent/CA2497660A1/en not_active Abandoned
- 2003-06-02 US US10/453,915 patent/US20040054146A1/en not_active Abandoned
- 2003-06-02 AT AT03740967T patent/ATE414540T1/de not_active IP Right Cessation
- 2003-06-02 ES ES03740967T patent/ES2316780T3/es not_active Expired - Lifetime
-
2008
- 2008-12-04 US US12/327,868 patent/US20090191268A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1545607A1 (de) | 2005-06-29 |
ES2316780T3 (es) | 2009-04-16 |
AU2003297953B2 (en) | 2009-02-26 |
CA2497660A1 (en) | 2004-03-18 |
US20040054146A1 (en) | 2004-03-18 |
WO2004022094A1 (en) | 2004-03-18 |
US20090191268A1 (en) | 2009-07-30 |
DE60324816D1 (de) | 2009-01-02 |
JP2006510588A (ja) | 2006-03-30 |
AU2003297953A1 (en) | 2004-03-29 |
EP1545607B1 (de) | 2008-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
DK1877390T3 (da) | Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf | |
TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
TW200745161A (en) | Stable antibody formulation | |
NO20071740L (no) | Humaniserte anti-beta7-antagonister og anvendelser derav | |
ATE507822T1 (de) | Stabilisierte zusammensetzungen von faktor-vii- polypeptiden | |
IL214325A (en) | Antibody against cmet, a drug that includes and uses it | |
MX2009013199A (es) | Anticuerpos anti-notch1 nnr y sus metodos de uso. | |
SG158141A1 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
SE0301653D0 (sv) | Novel compounds | |
NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
NO20052149D0 (no) | Vaksine. | |
RS51694B (en) | NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE | |
WO2003103571A3 (en) | VACCINES AGAINST FLAVIVIRUSES | |
WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
EA200601596A1 (ru) | Улучшенный состав 6-меркаптопурина | |
IL173929A0 (en) | Analogues of kahalalide f and pharmaceutical compositions containing the same | |
SE0301650D0 (sv) | Novel compounds | |
MX2007007355A (es) | 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor. | |
DE60324816D1 (de) | Impfstoffe gegen allergien | |
DE60326773D1 (de) | Peptid-deformylase-hemmer | |
ATE391489T1 (de) | Haarbehandlungszusammensetzungen | |
DE60207833D1 (de) | Peptiddeformylase-hemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |